非酒精性脂肪性肝病:临床实践中组织学发现的报告
美国肝病研究学会NASH工作组赞助的白皮书,聚焦疑似NAFLD患者肝活检评估,旨在为临床肝病医生和病理医生提供简洁具体的报告NASH组织病理学要素的方法,区分NASH与非酒精性单纯性脂肪肝及酒精性脂肪性肝炎,并讨论晚期纤维化或肝硬化及儿童人群的特殊情况。
要点
- 肝活检仍是药物研发和临床试验中诊断及患者筛选最特异的手段。
- 报告应涵盖NASH组织病理学要素,并与单纯性脂肪肝及酒精性肝炎鉴别。
- 需关注晚期纤维化或肝硬化及儿童NASH的特殊情况。
核心结论
- 肝活检评估仍是药物研发和临床试验中最特异的诊断和患者筛选手段。
研究设计与样本
- 美国肝病研究学会NASH工作组赞助的白皮书,聚焦临床肝病医生和病理医生对疑似NAFLD患者肝活检评估的综述。
主要发现
- 肝活检在NASH中的作用随疾病重要性认识增加而演变,药物研发和临床试验及无创标志物检测快速发展。
- 讨论包括晚期纤维化或肝硬化及儿童人群NASH的特殊情况。
- 讨论疾病活动度和纤维化病变的半定量评估方法。
- 提供评分表格和最终报告的建议模型。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The role of liver biopsy in NASH has evolved along with the increased recognition of the significance of this disease, and the unmet medical need it presents. Drug development and clinical trials are rapidly growing, as are noninvasive tests for markers of steatosis, inflammation, injury, and fibrosis. Liver biopsy evaluation remains necessary for both drug development and clinical trials as the most specific means of diagnosis and patient identification for appropriate intervention. This White Paper, sponsored by the American Association for the Study of Liver Disease NASH Task Force, is a focused review of liver biopsy evaluation in fatty liver disease in subjects with presumed NAFLD for practicing clinical hepatologists and pathologists. The goal is to provide succinct and specific means for reporting the histopathologic elements of NASH, distinguishing NASH from nonalcoholic fatty liver without steatohepatitis, and from alcohol-associated steatohepatitis when possible. The discussion includes the special situations of NASH in advanced fibrosis or cirrhosis, and in the pediatric population. Finally, there is discussion of semiquantitative methods of evaluation of lesions of "disease activity" and fibrosis. Tables are presented for scoring and a suggested model for final reporting. Figures are presented to highlight the histopathologic elements of NASH.
引用
- Brunt EM, Kleiner DE, Carpenter DH, et al. NAFLD: Reporting Histologic Findings in Clinical Practice. Hepatology. 2021. PMID: 33111374. doi:10.1002/hep.31599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。